Last week the Wonca Europe Conference 2016 was held in Copenhagen, more than 6,000 family physicians from all over the world attended.
It described how in March 2015 a group of 25 patients diagnosed with asthma was selected and invited to participate in the study. They were trained in the use of the platform to control asthma. They were also given a Peak Flow and were taught how to use it.
Patients’ clinical evolution was followed-up for 6 months, as well as their platform entries in order to collect several variables:
- Smoking facts
- Years since asthma was diagnosed
- Asthma attacks
- Treatments: evolution & level of the patient according to treatment
Before participating in the study, about 50% of patients had had to go to emergency visits at least once in the last year, some of them even up to 4 times. Since their participation in the study, none of the patients had to go to the emergency room.
Before entering the study more than 50% of patients had increased their treatment. During the study, none of them increased it, and 25% even decreased their treatment dose. 32% of patients improved their level according to the basic treatment.
After the study, 80% of patients have entered the data daily.
Medication adherence was above 95% in those who had used the platform regularly.
Patients Peak flow had a 7% increase over the initial values.
Conclusions: The study shows how Medtep Asma platform used in asthmatic patients improves their control and clinical evolution, decreases emergency room visits and reduces treatment.
Pedro J. Tárraga
Family Physician, Lecturer at the University of Castilla la Mancha